Achillion Pharma (ACHN) Raises $50M from Recent Share Sale

Between December 22, 2014 and December 31, 2014, Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) (the “Company”) sold shares of its common stock pursuant to the Sales Agreement, dated November 8, 2012, between the Company and Cantor Fitzgerald & Co., resulting in aggregate gross proceeds to the Company of $50 million. After giving effect to these sales, the Company estimates that its cash will be sufficient to meet its projected operating requirements into the fourth quarter of 2016.

You May Also Be Interested In

• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• Baiya International Group (BIYA) files $200M mixed shelf
• Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight